CVS CVS Health Corporation - Fundamental Analysis
BEARISH
CVS Stock | Fundamental Analysis & Investment Insights
NYSE
•
Healthcare
•
Healthcare Plans
Current Price
$80.13
Analyst Target
$94.6
+18.1% Upside
52W High
$85.15
52W Low
$44.92
At a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
Powered by advanced machine learning algorithms
Confidence Score
85%
Analysis Accuracy
The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of 4/9 (indicating borderline stability) and an implausibly high Altman Z-Score of 562438441676.8, which suggests potential data anomaly or extreme outlier conditions. Despite a strong revenue growth of 7.80% and a seemingly attractive forward P/E of 11.18, the company suffers from critically low profitability (0.12% net margin), deteriorating earnings (YoY EPS growth: -387.2%), and a dangerously high payout ratio of 700%, raising sustainability concerns. Insider selling and poor recent earnings surprises further undermine confidence, while the stock trades significantly above the Graham Number of $22.16, indicating substantial overvaluation relative to defensive criteria.
Key Strengths
Revenue growth of 7.80% YoY outpaces some peers in the healthcare sector
Forward P/E of 11.18 is below sector average, suggesting potential value if earnings stabilize
Dividend yield of 3.32% is above market average, offering income appeal
Enterprise-scale presence in healthcare with $101.72B market cap provides operational resilience
Recent price momentum is strong, with +89.0% 1-year return
Key Risks
Critically low Piotroski F-Score of 4/9 indicates weak financial health and poor earnings quality
Net profit margin of 0.12% is abnormally low for the sector and unsustainable long-term
Payout ratio of 700% implies dividends are not earnings-supported, creating high risk of cut
Severe earnings deterioration: YoY EPS growth of -387.2% and Q/Q EPS drop of -491.2%
Insider selling activity signals lack of confidence from corporate insiders
AI Fair Value Estimate
Based on comprehensive analysis
$22.16
-72.3% below current price
Performance Snowflake
Multi-dimensional AI analysis across 5 key categories
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Historical Performance Trends
Long-term financial metrics and growth patterns
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability, Growth & Financial Health
Detailed profit margins, ROE, debt ratios, and liquidity metrics
Sector Comparison & Peer Analysis
Compare CVS against industry averages and similar companies
Insider Trading & Analyst Ratings
Track insider transactions and Wall Street analyst recommendations